APA

Sadanaga N., Nagashima H., Mashino K., Tahara K., Yamaguchi H., Ohta M., Fujie T., Tanaka F., Inoue H., Takesako K., Akiyoshi T. & Mori M. (20011018). Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Sadanaga N, Nagashima H, Mashino K, Tahara K, Yamaguchi H, Ohta M, Fujie T, Tanaka F, Inoue H, Takesako K, Akiyoshi T and Mori M. 20011018. Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Sadanaga N., Nagashima H., Mashino K., Tahara K., Yamaguchi H., Ohta M., Fujie T., Tanaka F., Inoue H., Takesako K., Akiyoshi T. and Mori M. (20011018). Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Sadanaga N, Nagashima H, Mashino K, Tahara K, Yamaguchi H, Ohta M, Fujie T, Tanaka F, Inoue H, Takesako K, Akiyoshi T and Mori M. Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20011018.